Glucocorticoids and endothelial cell barrier function

Cell and Tissue Research

Volumn 355, Issue 3, 2014, Pages 597-605

  Salvador, Ellaine ^a   Shityakov, Sergey ^a   Förster, Carola ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Blood brain barrier; Endothelial cells; Glucocorticoid receptor; Glucocorticoids

Indexed keywords

GLUCOCORTICOID;

ANIMAL; BLOOD BRAIN BARRIER; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; METABOLISM; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUCOCORTICOIDS; HUMANS;

EID: 84899413012     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1762-z     Document Type: Review

References (101)

1. Anko-Akatsuka Y, Saitou M, Hirase T, Kishi M, Sakakibara A, Itoh M, Yonemura S, Furuse M, Tsukita S (1996) Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J Cell Biol 133:43-47
2. Avolio C, Filippi M, Tortorella C, Rocca MA, Ruggieri M, Agosta F, Tomassini V, Pozzili C, Stecchi S, Giaquinto P, Livrea P, Trojano M (2005) Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler 11:441-446
3. Balda MS, Whitney J, Flores C, Gonzalez S, Cereijido M, Malter K (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031-1049
4. Ballabh P, Braun A, Nedergaard M (2004) The blood brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiol Dis 16:1-13
5. Bamforth SD, Kniesel U, Wolburg H, Engelhardt B, Risau W (1999) A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci 112:1879-1888
6. Beato M (1989) Gene regulation by steroid hormones. Cell 56:335-344
7. Blecharz KG, Drenckhahn D, Förster CY (2008) Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J Cereb Blood Flow Metab 28:1139-1149
8. Blecharz KG, Haghikia A, Stasiolek M, Kruse N, Drenckhahn D, Gold R, Roewer N, Chan A, Förster CY (2010) Glucocorticoid effects on endothelial barrier function in the murine barin endothelial cell line cEND incubated with sera from patients with multiple sclerosis. Mult Scler 16:293-302
9. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochem Biophys Acta 1477:267-283
10. Burek M, Förster CY (2009) Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol 298:19-24
11. Burek M, Arias-Loza PA, Roewer N, Förster C (2010) Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler Thromb Vasc Biol 30:298-304
12. Buse P, Woo PL, Alexander DB, Reza A, Firestone GL (1995) Glucocorticoid-induced functional polarity of growth factor responsiveness regulates tight junction dynamics in transformed mammary epithelial tumor cells. J Biol Chem 270:28223-28227
13. Calabria AR, Weidenfeller C, Jones AR, de Vries HE, Shusta EV (2006) Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem 97:922-933
14. Carmeliet P, Lampugnani M, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98:147-157
15. Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37-S43
16. Citi S (1993) The molecular organization of tight junctions. J Cell Biol 121:485-489
17. Crosby CV, Fleming P, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ (2005) VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105:2771-2776
18. Dao-Phan HP, Formstecher P, Lefebvre P (1997) Disruption of the glucocorticoid receptor assembly with heat shock protein 90 by a peptidic antiglucocorticoid. Mol Endocrinol 11:962-972
19. De Reuck J, Vandekerckhove T, Bosma G, De Meulemeester K, Van Landegem W, De Waele J, Tack E, De Koninck J (1988) Steroid treatment in acute ischaemic stroke. A comparative retrospective study of 556 cases. Eur Neurol 28:70-72
20. Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5:261-270
21. Dejana E, Bazzoni G, Lampugnani MG (1999) Vascular endothelial (VE)-cadherin: only an intercellular glue? Exp Cell Res 252:13-19
22. Dittmar KD, Demady D, Stancato LF, Krishna P, Pratt WB (1997) Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J Biol Chem 272:21213-21220
23. Drouin J, Lu Y, Nemer M (1989) Glucocorticoid repression of pro-opiomelanocortin gene transcription. J Steroid Biochem 34:63-69
24. Engelhardt B (2006) Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 113:477-485
25. Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L, Adams JM, Strasser A, Villunger A (2005) BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106:4131-4138
26. Ernst A, Sidhu S (2013) Engineering ubiquitin to modulate the ubiquitin proteosome system. Cell Cycle 12:1651-1652
27. Evans R (1988) The steroid and thyroid hormone superfamily. Science 240:889-895
28. Felinski EA, Cox A, Phillips BE, Antonetti DA (2008) Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 86:867-878
29. Förster C (2008) Tight junctions and the modulation of barrier function ion disease. Histochem Cell Biol 130:55-70
30. Förster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, Drenckhahn D (2005) Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol (Lond) 565:475-486
31. Förster C, Waschke J, Burek M, Leeres J, Drenckhahn D (2006) Glucocorticoid effects on microvascular endothelial barrier permeability are brain specific. J Physiol (Lond) 573:413-425
32. Förster C, Kietz S, Kahles T, Drenckhahn D (2007) Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol (Lond) 580:937-949
33. Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D (2008) Differential effects of hydrocortisone and TNF alpha on tight junction proteins in an in vitro model of the human blood brain barrier. J Physiol (Lond) 586:1937-1949
34. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-1788
35. Furuse M, Fujimoto K, Sato N, Hirase T, Tsukita S (1996) Overexpression of occludin, a tight-junction associated integral membrane protein, induces the formation of intracellular multi-lamellar bodies bearing tight junction-like structures. J Cell Sci 109:429-435
36. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S (1998) Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539-1550
37. Gavard J (2009) Breaking the VE-cadherin bonds. FEBS Lett 583:1-6
38. Gelati M, Corsini E, Dufour A, Massa G, Giombini S, Solero CL, Salmaggi A (2000) High-dose methylprednisolone reduces cytokine-induced adhesion molecules on human brain endothelium. Can J Neurol Sci 27:241-244
39. Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953-1971
40. Gonzalez-Mariscal L, Betanzos A, Nava P, Jamarillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81:1-44
41. Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622-634
42. Harke N, Leers J, Kietz S, Drenckhahn D, Förster C (2008) Identification of a distal glucocorticoid responsive element in the occludin gene coding region. Mol Cell Endocrinol 295:39-47
43. Harkness KA, Adamson P, Sussman JD, Davies-Jones GA, Greenwood J, Woodroofe MN (2000) Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123:698-709
44. Hartmann C, El-Gindi J, Lohmann C, Lischper M, Zeni P, Galla HJ (2009) TIMP-3: a novel target for glucocorticoid signaling at the blood-brain barrier. Biochem Biophys Res Commun 390:182-186
45. Hawle P, Siepmann M, Harst A, Siderius M, Reusch HP, Obermann WM (2006) The middle domain of Hsp90 acts as a discriminator between different types of client protein. Mol Cell Biol 26:8385-8395
46. Hoheisel D, Nitz T, Franke H, Wegener J, Hakvoort A, Tilling T, Galla HJ (1998) Hydrocortisone reinforces the blood brain barrier properties in a serum-free cell-culture system. Biochem Biophys Res Commun 244:312-316
47. Kahle KT, Simard J, Staley KJ, Nahed BV, Jones PS, Sun D (2009) Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 24:257-265
48. Kleinschnitz C, Blecharz K, Kahles T, Schwarz T, Kraft P, Thum T, Stoll G, Förster C (2011) Glucocorticoid insensitivity at the hypoxic blood-brain-barrier can be reversed by inhibition of the proteasome. Stroke 42:1081-1089
49. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE (2008) Structure and function of claudins. Biochim Biophys Acta 1778:631-645
50. Kumar N, Jain S, Maheshwari MC (1989) Role of dexamethasone in the outcome from acute stroke. J Assoc Physicians India 37:315-317
51. Leach L, Lammiman M, Babawale MO, Hobson SA, Bromilou B, Lovat S, Simmonds MJ (2000) Molecular organization of tight and adherens junctions in the human placental vascular tree. Placenta 21:547-557
52. Lewis-Tuffin LJ, Cidlowski J (2006) The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 1069:1-9
53. Lohmann C, Hüwel S, Galla HJ (2002) Predicting blood brain barrier permeability of drugs: evaluation of different in vitro assays. J Drug Target 10:263-276
54. Lu NZ, Cidlowski J (2004) The origin and functions of multiple human glucocorticoid receptor isoforms. Ann N Y Acad Sci 1024:102-123
55. Madara J (1988) Tight junction dynamics: is paracellular transport regulated? Cell 53:497-498
56. Madra JL, Barenberg D, Carlson S (1986) Effects of cytochalasin D on occludin junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 102:2125-2136
57. McCarthy KM, Skare I, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE (1996) Occludin is a functional component of the tight junction. J Cell Sci 109:2287-2298
58. Meller R (2009) The role of the ubiqutitin proteosome system in ischemia and ischemic tolerance. Neuroscientist 15:243-260
59. Milligan NM, Newcombe R, Compston DA (1987) A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis. 1. Clinical effects. J Neurol Neurosurg Psychiatry 50:511-516
60. Mirowska-Guzel DM, Kurowska K, Skierski J, Koronkiewicz M, Wicha W, Kruszewska J, Czlonkowski A, Czlonkowska A (2006) High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse. J Neuroimmunol 176:134-140
61. Nakai Y, Usui T, Tsukada T, Takahashi H, Fukata J, Fukushima M, Senoo K, Imura H (1991) Molecular mechanisms of glucocorticoid inhibition of human pro-opiomelanocortin gene transcription. J Steroid Biochem Mol Biol 40:301-306
62. Neuwelt E, Abbott N, Abrey L, Banks WA, Blakley B, Davis T, Engelhardt B, Grammas P, Nedergaard M, Nutt J, Pardridge W, Rosenberg GA, Smith Q, Drewes LR (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7:84-96
63. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood brain barrier in claudin-5 deficient mice. J Cell Biol 161:653-660
64. Norris J (2004) Steroids may have a role in stroke therapy. Stroke 35:228-229
65. Norris JW, Hachinski V (1986) High dose steroid treatment in cerebral infarction. BMJ 292:21-23
66. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
67. Paul C, Bolton C (1995) Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int J Immunopharmacol 17:497-503
68. Picard D, Salser S, Yamamoto KR (1988) A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54:1073-1080
69. Poungvarin N (2004) Steroids have no role in stroke therapy. Stroke 35:229-230
70. Pujols L, Mullol J, Pérez M, Roca-Ferrer J, Juan M, Xaubet A, Cidlowski JA, Picado C (2001) Expression of human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol 24:49-57
71. Reichhardt H (2004) Immunomodulatory activities of glucocorticoids: insights from transgenesis and gene targeting. Curr Pharm Des 10:2797-2805
72. Rhen T, Cidlowski J (2005) Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353:1711-1723
73. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloe V, Munoz-Sanchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364:1321-1328
74. Romero IA, Radewicz K, Jubin E, Michel CC, Greenwood J, Couraud PO, Adamson P (2003) Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci Lett 344:112-116
75. Sadowska GB, Malaeb S, Stonestreet BS (2010) Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. Am J Physiol Heart Circ Physiol 298:H179-H188
76. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S (1998) Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141:397-408
77. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11:4131-4142
78. Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman FM, Yamamoto KR (1988) Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev 2:1144-1154
79. Saul TG, Ducker T, Salcman M, Carro E (1981) Steroids in severe head injury: a prospective randomized clinical trial. J Neurosurg 54:596-600
80. Schaaf MJM, Cidlowski J (2003) Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37-48
81. Schneeberger EE, Lynch RD (1992) Structure, function and regulation of cellular tight junctions. Am J Physiol 262:L647-L661
82. Schweingruber N, Reichardt S, Lühder F, Reichardt HM (2011) Mechanisms of glucocorticoids in the control of neuroinflammation. J Neuroendocrinol 24:174-182
83. Screpanti I, Morrone S, Meco D, Santoni A, Gulino A, Paolini R, Crisanti A, Mathieson BJ, Frati L (1989) Steroid sensitivity of thymocyte subpopulations during intrathymic differentitation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J Immunol 142:3378-3383
84. Silwedel C, Förster C (2006) Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J Neuroimmunol 179:37-45
85. Singer KL, Stevenson B, Woo PL, Firestone GL (1994) Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in non-transformed mammary epithelial cells. J Biol Chem 269:16108-16115
86. Sloka JS, Stefanelli M (2005) The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler 11:425-432
87. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
88. Steinman L (2001) Multiple sclerosis: a two-stage disease. Nat Immunol 2:762-764
89. Subramaniam N, Cairns W, Okret S (1998) Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. J Biol Chem 273:23567-23574
90. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923-934
91. Tischner D, Reichardt H (2007) Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol 275:62-70
92. Tsai MJ, O'Malley BW (1995) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
93. Tsukita S, Furuse M, Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285-293
94. Umland SP, Schleimer R, Johnston SL (2002) Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Therap 15:35-50
95. Wallace AD, Cidlowski J (2001) Proteosome-mediated glucocorticoid receptor degradation resticts transcriptional signaling by glucocorticoids. J Biol Chem 276:42714-42721
96. Wang D, Müller N, McPherson KG, Reichardt HM (2006) Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J Immunol 176:1695-1702
97. Weidenfeller C, Schrot S, Zozulya A, Galla HJ (2005) Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res 1053:162-174
98. Weksler BB, Subileau E, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greewnrood J, Romero IA, Couraud PO (2005) Blood brain barrier specific properties of a human adult brain endothelial cell line. FASEB J 19:1872-1874
99. Wikstrom AC, Okret S, Bakke O, Fuxe K, Gustafsson JA (1986) Glucocorticoid mechanism of action: monoclonal antibodies as experimental tools. Med Oncol Tumor Pharmacother 3:185-196
100. Wolburg H, Lippoldt A (2002) Tight junctions of the blood brain barrier: development, composition and regulation. Vasc Pharmacol 2002:323-337
101. Yang Y, Estrada E, Thompson JF, Liu W, Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697-709